Lavender Sky Health vs IVIM Health

Lavender Sky Health vs IVIM Health at every dose

A single headline figure assumes a maintenance dose neither you nor your prescriber has chosen yet. This is the same comparison at all six strengths.

What differs beyond price

Price is the easiest thing to compare and rarely the thing that decides satisfaction. These are the attributes each programme publishes.

Which one, for whom

If you want the lowest total cost: IVIM Health at about $3,219 for a first year.

If you want budget certainty: neither has an advantage — both use the same pricing model.

If you want to verify the supply chain: IVIM Health, which names its dispensing pharmacy.

If you may need to stop early: compare the cancellation rows above before prepaying. Compounded medication is generally not refundable once it has shipped, so a multi-month term is the wrong structure during titration, when intolerance is the most likely reason to stop.

Switching between them

Usually possible after a clinical review, and the two real risks are a supply gap while a new intake is processed and a new prescriber restarting titration rather than continuing your dose. Confirm dose continuity in writing before cancelling anything, because a month back at 2.5 mg is a month of lost progress no price difference recovers.

If you are already on one of them

Moving from Lavender Sky Health to IVIM Health is worth $752 over a year. Set that against two real switching costs: a gap in supply while a new intake is reviewed, and the possibility that a new prescriber restarts titration rather than continuing your dose. Ask about dose continuation in writing before cancelling anything, because a month back at 2.5 mg is a month of lost progress no price difference recovers.

Fee structure, side by side

Lavender Sky Health charges a mandatory membership of $25 a month on top of medication. IVIM Health charges a mandatory membership of $75 a month.

This is where most published comparisons break. A table quoting medication alone understates a membership programme by the full fee, every month, for as long as you stay. Every figure here folds it in, which is why our number can be higher than the one on a programme's own homepage.

Care model and what it buys

Lavender Sky Health: visit model not published, labs not published, coaching not published. IVIM Health: video, labs required, included.

Video visits, included laboratory work and real clinician access cost money to provide, and programmes providing them are rarely cheapest. That is what you are paying for. The failure is paying a premium for an asynchronous questionnaire a cheaper programme provides identically.

Verification, which outranks both

Lavender Sky Health: pharmacy not disclosed. IVIM Health: not named.

A programme that will not name the pharmacy compounding your medicine is asking you to inject an unidentified preparation weekly. State boards publish licensee registers and FDA publishes outsourcing-facility registrations and warning letters, all free and searchable — but only if you have a name. That question outranks a price difference of almost any size.

Which is cheaper depends on where you land

A single annual comparison assumes one maintenance dose. This runs both programmes at every plausible outcome, over one year and three.

Read the final column before the first. A gap that looks modest over twelve months compounds into the three-year figure, and the withdrawal evidence for this drug class means three years is the more honest planning horizon.

What each one is actually charging for

Lavender Sky Health: $327 medication plus $25 platform fee, $300 a year. IVIM Health: $203 medication plus $75 platform fee, $900 a year.

Comparing the medication figures alone would make IVIM Health look $50 a month cheaper than it is. That is the single most common distortion in published comparisons of these two.

Where the money actually separates

A single annual figure hides when the gap opens. Tracked month by month through a first year you can see whether the difference is front-loaded during titration or accumulates quietly at maintenance.

Across the year the gap reaches $752, roughly 19% of the larger total and about 2.7 months of therapy at IVIM Health's maintenance rate. Over three years at a stable dose the same difference compounds to roughly $2,664.

Does the answer change with your dose?

The answer flips at 5 mg. Below it Lavender Sky Health costs less; from there upward IVIM Health does. If your prescriber has not decided your maintenance dose, this comparison genuinely has no single answer, and the flat-rate option is the hedge against that uncertainty.

Commitment and what each puts at risk

Lavender Sky Health publishes no prepaid term. IVIM Health publishes no prepaid term.

Prepaying lowers the rate and makes the money effectively unrecoverable, because compounded medication is generally not refundable once shipped. During titration that is the wrong structure: it commits against the most likely reason to stop. After a stable cycle at maintenance it is reasonable.

Care model and what you can verify

Lavender Sky Health: visit model not published, labs not published, pharmacy not published, cancellation not published.

IVIM Health: video, labs required, pharmacy not named, cancellation membership mandatory.

Where one names a pharmacy and the other does not, that difference outranks a modest price gap. It is the only disclosure that lets you check a public register before injecting something weekly, and it costs a programme nothing to publish.

If you are already on one of them

Moving from Lavender Sky Health to IVIM Health is worth $752 over a year, about 2.7 months of therapy at the cheaper rate. Set that against two real switching costs: a supply gap while an intake is reviewed, and the possibility that a new prescriber restarts titration.

Ask about dose continuation in writing before cancelling anything. A month back at 2.5 mg is a month of lost progress that no price difference recovers, and it is the most common regret reported by people who switched for a small saving.

What neither table can tell you

Shipping reliability, how fast a clinician actually replies, whether a dose adjustment takes two days or two weeks, and what happens when a cold-chain shipment fails. Those decide satisfaction more than price does, and we hold no measurements of them we would defend, so they are absent rather than estimated.

The one usable proxy is what each programme publishes before it has your money. A programme that states its price at every dose, names its pharmacy and puts cancellation terms in writing has already told you something about how it behaves when there is a problem.

Running this comparison again later

Both figures carry a capture date and both will change. Programmes do not notify existing patients when a competitor drops below them, and several tracked programmes moved pricing more than once in the past year.

Re-run this at your actual maintenance dose annually, and treat any figure older than a month as needing a re-check before you act on it.

Where both of these sit in the wider market

Lavender Sky Health at $3,971 and IVIM Health at $3,219 for a first year sit against a market running from $2,580 to $7,164. Both are at the cheaper end of what we track.

If neither is close to the cheapest tracked route, the useful question is not which of these two wins but why you are choosing between these two at all. The comparison matrix will show what else is available at your dose in about ten seconds.

If you are already on one of them

Moving from Lavender Sky Health to IVIM Health is worth $752 over a year. Set that against two real switching costs: a gap in supply while a new intake is reviewed, and the possibility that a new prescriber restarts titration rather than continuing your dose. Ask about dose continuation in writing before cancelling anything, because a month back at 2.5 mg is a month of lost progress no price difference recovers.

Fee structure, side by side

Lavender Sky Health charges a mandatory membership of $25 a month on top of medication. IVIM Health charges a mandatory membership of $75 a month.

This is where most published comparisons break. A table quoting medication alone understates a membership programme by the full fee, every month, for as long as you stay. Every figure here folds it in, which is why our number can be higher than the one on a programme's own homepage.

Care model and what it buys

Lavender Sky Health: visit model not published, labs not published, coaching not published. IVIM Health: video, labs required, included.

Video visits, included laboratory work and real clinician access cost money to provide, and programmes providing them are rarely cheapest. That is what you are paying for. The failure is paying a premium for an asynchronous questionnaire a cheaper programme provides identically.

Verification, which outranks both

Lavender Sky Health: pharmacy not disclosed. IVIM Health: not named.

A programme that will not name the pharmacy compounding your medicine is asking you to inject an unidentified preparation weekly. State boards publish licensee registers and FDA publishes outsourcing-facility registrations and warning letters, all free and searchable — but only if you have a name. That question outranks a price difference of almost any size.

Which is cheaper depends on where you land

A single annual comparison assumes one maintenance dose. This runs both programmes at every plausible outcome, over one year and three.

Read the final column before the first. A gap that looks modest over twelve months compounds into the three-year figure, and the withdrawal evidence for this drug class means three years is the more honest planning horizon.

What each one is actually charging for

Lavender Sky Health: $327 medication plus $25 platform fee, $300 a year. IVIM Health: $203 medication plus $75 platform fee, $900 a year.

Comparing the medication figures alone would make IVIM Health look $50 a month cheaper than it is. That is the single most common distortion in published comparisons of these two.

The gap between Lavender Sky Health and IVIM Health

IVIM Health costs $74 a month less than Lavender Sky Health at a 10 mg maintenance dose — $278 against $352 — which compounds to $752 across a first year, a 23% difference.

Both dispense the same molecule. The gap is overhead, clinical wrap, pharmacy sourcing and margin, not a difference in what arrives in the vial.

Same structure, different number

Both price by dose, so the comparison stays stable wherever you settle. IVIM Health is cheaper at every strength, by $74 a month at maintenance.

When two programmes share a pricing structure, the remaining differences are care model, pharmacy disclosure and cancellation terms rather than arithmetic.

If you are weighing semaglutide instead

Both programmes carry compounded semaglutide as well as tirzepatide. Lavender Sky Health prices semaglutide at $174 a month all-in against $352 for tirzepatide; IVIM Health prices it at $224 against $278. On semaglutide the cheaper of the two is Lavender Sky Health, by $50 a month.

Note that the tirzepatide answer and the semaglutide answer are not the same programme here. If you are undecided between molecules, that matters, because switching molecules later may also mean switching programmes to keep the better price.

The semaglutide premium runs $178 a month at Lavender Sky Health and $54 at IVIM Health. Tirzepatide costs more at both because the peptide is longer and harder to synthesise, not because either programme is marking it up unusually. Whether that premium is worth paying is a clinical question: SURMOUNT-5 reported greater mean weight reduction on tirzepatide over 72 weeks, while semaglutide carries the larger cardiovascular outcomes evidence base.

Pharmacy disclosure on both sides

Neither programme names the dispensing pharmacy before purchase, so neither can be checked independently in advance. Ask in writing which pharmacy fills the prescription and whether it is a 503A or 503B facility.